📣 VC round data is live. Check it out!
- Public Comps
- Alibaba Health
Alibaba Health Valuation Multiples
Discover Alibaba Health's revenue and EBITDA valuation multiples and investment history, alongside public comparables like Nykaa, Zalando, Vipshop, Meesho and more.
Alibaba Health Overview
About Alibaba Health
Alibaba Health is of one of China's leading e-commerce platform specializing in healthcare-related products, including prescription drugs, OTC drugs, traditional Chinese medicine, health foods, and so on. The company operates both a third-party B2C service, or 3P, and its own direct-to-consumer business, or 1P, with its own inventory, which can both be accessed by Alibaba’s Tmall app and Alipay. The company also provides online consultation services in a separate app called Yilu or “Dr. Deer,” although its e-commerce businesses remain its core competency in the long-term. E-commerce accounted for 93% of revenue in fiscal year 2022. We estimate that AliHealth holds about 45% of market share in the industry in terms of GMV. AliHealth is 63.74% owned by its parent company, Alibaba Group.
Founded
1998
HQ

Employees
1.4K
Website
Financials (LTM)
EV
$6B
Valuation Multiples
Start free trialAlibaba Health Financials
Alibaba Health reported last 12-month revenue of $5B and EBITDA of $296M.
In the same LTM period, Alibaba Health generated $1B in gross profit, $296M in EBITDA, and $287M in net income.
Revenue (LTM)
Alibaba Health P&L
In the most recent fiscal year, Alibaba Health reported revenue of $5B and EBITDA of $239M.
Alibaba Health is profitable as of last fiscal year, with gross margin of 24%, EBITDA margin of 5%, and net margin of 5%.
Financial data powered by Morningstar, Inc.
Alibaba Health Stock Performance
Alibaba Health has current market cap of $8B, and enterprise value of $6B.
Market Cap Evolution
Alibaba Health's stock price is $0.48.
Alibaba Health share price increased by 3.0% in the last 30 days, and decreased by 21.1% in the last year.
Alibaba Health has an EPS (earnings per share) of $0.01.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $6B | $8B | 3.0% | 3.0% | -19.8% | -21.1% | $0.01 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialAlibaba Health Valuation Multiples
Alibaba Health trades at 1.2x EV/Revenue multiple, and 21.0x EV/EBITDA.
EV / Revenue (LTM)
Alibaba Health Financial Valuation Multiples
As of June 2, 2026, Alibaba Health has market cap of $8B and EV of $6B.
Alibaba Health has a P/E ratio of 26.8x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Alibaba Health Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Alibaba Health Margins & Growth Rates
Alibaba Health grew revenue by 11% and EBITDA by 21% in the last fiscal year.
In the most recent fiscal year, Alibaba Health reported gross margin of 24%, EBITDA margin of 5%, and net margin of 5%.
Alibaba Health Margins
Alibaba Health Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Alibaba Health Operational KPIs
Alibaba Health's revenue per employee in the last FY averaged $3.3M, while opex per employee averaged $0.6M for the same period.
Alibaba Health's Rule of 40 is 19% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Alibaba Health's Rule of X is 38% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Alibaba Health Competitors
Alibaba Health competitors include Nykaa, Zalando, Vipshop, Meesho, Droga Raia, Chewy, Lenskart, Vishal Mega Mart, Wayfair and MatsukiyoCocokara.
Most Alibaba Health public comparables operate across Pharmacies, Vertical E-commerce, Consumer E-commerce and HealthTech.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 7.7x | 7.4x | 100.1x | 95.3x | |||
| 0.4x | 0.4x | 6.1x | 5.7x | |||
| 0.2x | 0.2x | 2.2x | 2.3x | |||
| 6.1x | 5.8x | (67.2x) | (60.4x) | |||
| 0.9x | 0.9x | 11.5x | 11.4x | |||
| 0.7x | 0.7x | 12.2x | 11.1x | |||
| 10.0x | 9.5x | 46.6x | 47.1x | |||
| 4.3x | 4.2x | 28.3x | 28.9x | |||
This data is available for Pro users. Sign up to see all Alibaba Health competitors and their valuation data. Start Free Trial | ||||||
Investments by Alibaba Health
Alibaba Health has invested in 6 companies to date.
Latest investment by Alibaba Health was on July 31st 2023. Alibaba Health invested in Atantares in their $14M Seed round (EV/Revenue multiple available to Pro users).
Latest Investments by Alibaba Health
| Description | Atantares is a semiconductor technology firm advancing biomedicine through silicon-based microfluidics. The company leverages chip miniaturization and integration to deliver ultra-high throughput and sensitivity for applications in medical diagnostics, synthetic biology, and DNA data storage. Headquartered in Shenzhen, China, Atantares addresses demands in healthcare and biotech by providing scalable platforms that handle complex fluidic processes at microscopic scales. | Landing Medical High Technology is a med-tech firm creating AI-driven diagnostic technology for cervical cancer screening. Its Landing Shares platform processes colposcopy images to detect precancerous lesions with high sensitivity. The company operates from China, supplying tools to women's health clinics across Asia. | Gene+ is a China-based precision oncology company offering genetic testing for cancer prevention and treatment. The firm conducts gene panel sequencing in partnership with over 100 hospitals nationwide. Its diagnostics cover tumor profiling, companion diagnostics, and monitoring services. Gene+ operates advanced sequencing laboratories to support oncologists with actionable genomic insights. | Guizhou Ensure Chain Pharmacy Company is a Guiyang-headquartered retail chain operating over 300 pharmacies across Guizhou province. The firm sells prescription drugs, over-the-counter medicines, and health products through urban and rural outlets. Guizhou Ensure Chain provides online ordering via WeChat and delivery services, partnering with provincial hospitals for medication distribution since its 2005 founding. | |
| HQ Country | |||||
| HQ City | Shanghai | Wuhan | Beijing | Guizhou | |
| Deal Date | 31 Jul 2023 | 10 Nov 2021 | 22 Jul 2021 | 21 Aug 2018 | |
| Round | Seed | Series D | Series C | Strategic investment | |
| Raised | $14M | $50M | $116M | $126M | |
| Investors | Alibaba Health; Asia Green Fund; Fosun Health Capital; Frees Fund; NeuX Capital; Next Capital; Qiming Venture Partners | Alibaba Health; Ether Capital | Alibaba Health; Baidu Ventures; CCB Capital; CCB International; Fortune Capital; Fortune Venture Capital; GGV Capital; Harvest Capital; Jinmao Capital; Junci Investment; Sharewin Investment | Alibaba Health | |
| Valuation | undisclosed | undisclosed | undisclosed | $421M | |
| EV/Revenue | |||||
| EV/EBITDA | |||||
This data is available for Pro users. Sign up to see all Alibaba Health investments and their VC round multiples. Start Free Trial | |||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Alibaba Health
| When was Alibaba Health founded? | Alibaba Health was founded in 1998. |
| Where is Alibaba Health headquartered? | Alibaba Health is headquartered in China. |
| How many employees does Alibaba Health have? | As of today, Alibaba Health has over 1K employees. |
| Who is the CEO of Alibaba Health? | Alibaba Health's CEO is Difan Shen. |
| Is Alibaba Health publicly listed? | Yes, Alibaba Health is a public company listed on HKEX. |
| What is the stock symbol of Alibaba Health? | Alibaba Health trades under 00241 ticker. |
| When did Alibaba Health go public? | Alibaba Health went public in 1972. |
| Who are competitors of Alibaba Health? | Alibaba Health main competitors include Nykaa, Zalando, Vipshop, Meesho, Droga Raia, Chewy, Lenskart, Vishal Mega Mart, Wayfair, MatsukiyoCocokara. |
| What is the current market cap of Alibaba Health? | Alibaba Health's current market cap is $8B. |
| What is the current revenue of Alibaba Health? | Alibaba Health's last 12 months revenue is $5B. |
| What is the current revenue growth of Alibaba Health? | Alibaba Health revenue growth (NTM/LTM) is 13%. |
| What is the current EV/Revenue multiple of Alibaba Health? | Current revenue multiple of Alibaba Health is 1.2x. |
| What is the current EBITDA of Alibaba Health? | Alibaba Health's last 12 months EBITDA is $296M. |
| What is Alibaba Health's EBITDA margin? | Alibaba Health's last 12 months EBITDA margin is 6%. |
| What is the current EV/EBITDA multiple of Alibaba Health? | Current EBITDA multiple of Alibaba Health is 21.0x. |
| What is the current FCF of Alibaba Health? | Alibaba Health's last 12 months FCF is $199M. |
| What is Alibaba Health's FCF margin? | Alibaba Health's last 12 months FCF margin is 4%. |
| What is the current EV/FCF multiple of Alibaba Health? | Current FCF multiple of Alibaba Health is 31.2x. |
| How many companies Alibaba Health has acquired to date? | Alibaba Health hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Alibaba Health has invested to date? | As of June 2026, Alibaba Health has invested in 6 companies. |
| What was the last Alibaba Health investment? | On 31st July 2023 Alibaba Health invested in Atantares, participating in a $14M Seed round, alongside Asia Green Fund, Fosun Health Capital, Frees Fund, NeuX Capital, Next Capital, and Qiming Venture Partners. |
| In what companies Alibaba Health invested in? | Alibaba Health invested in Guizhou Ensure Chain Pharmacy Company, One Tree Pharmaceutical, Gene+, Landing Medical High Technology, Wanliyun Medical Information Technology, and Atantares. |
See public comps similar to Alibaba Health
Lists including Alibaba Health
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.
